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Viruses, including retroviruses like human immuno-
deficiency virus (HIV) and mouse mammary tumor
virus (MMTV), are transmitted from mother to infants
through milk. Lymphoid cells and antibodies are
thought to provide mammary gland and milk-borne
immunity. In contrast, little is known about the role
of mammary epithelial cells (MECs). The APOBEC3
family of retroviral restriction factors is highly ex-
pressed in macrophages and lymphoid and dendritic
cells. We now show that APOBEC3 proteins are also
expressed in mouse and human MECs. Lymphoid
cell-expressed APOBEC3 restricts in vivo spread of
MMTV to lymphoid andmammary tissue. In contrast,
mammary gland-expressed APOBEC3 is packaged
into MMTV virions and decreases the infectivity of
milk-borne viruses. Moreover, APOBEC3G and other
APOBEC3 genes are expressed in human mammary
cells and have the potential to restrict viruses pro-
duced in this cell type. These data point to a role
for APOBEC3 proteins in limiting infectivity of milk-
transmitted viruses.
INTRODUCTION
A number of viruses are transmitted through milk from mother to
infants, including cytomegalovirus (Meier et al., 2005), vaccinia
virus (Abrahao et al., 2009), papillomaviruses (Lindsey et al.,
2009; Sarkola et al., 2008), and the retroviruses HIV, simian
immunodeficiency virus (SIV), feline immunodeficiency virus
(FIV), human T cell leukemia virus (HTLV) I/II, and MMTV (Allison
and Hoover, 2003; Li et al., 2004; Nandi and McGrath, 1973;
O’Neil et al., 1995; Rychert et al., 2006; Sellon et al., 1994; Seltzer
and Benjamin, 1990; Ziegler et al., 1985). The best-studied milk-
transmitted virus is the murine retrovirus, MMTV, which causes
breast cancer in mice (Nandi and McGrath, 1973). MMTV
in vivo infection occurs first in dendritic cells (DCs) of the gut,
which then transfer the virus to lymphocytes (Ross, 2008). The534 Cell Host & Microbe 8, 534–543, December 16, 2010 ª2010 Elseinfected lymphocytes traffic to the mammary gland, resulting in
the infection of mammary epithelial cells (MECs) during puberty
and pregnancy. Lactating mice shed high levels of cell-free virus
into milk, which is then acquired by nursing offspring during the
first week of life (Ross, 2008).
In addition to being a source of virus that can be transmitted
via milk, lymphoid cells in the mammary gland and milk provide
passive immunity to the neonate against pathogenic infections
(Walker, 2004). Indeed, strong neutralizing anti-MMTV humoral
responses in mice result in antibody-coated milk-borne virions
that are rendered noninfectious and are not transmitted to
newborns (Case et al., 2005). Moreover, it has been suggested
that anti-HIV antibodies in human milk block milk-borne trans-
mission (Bouhlal et al., 2005) and that CD8+ T lymphocytes
control SIV replication in breast milk lymphocytes (Permar
et al., 2008), thereby potentially limiting milk-transmitted infec-
tion (John-Stewart et al., 2009). In contrast to the important
role that lymphoid cells play in providing mammary gland and
milk-borne immunity, little is known about howMECs participate
in this process.
Recently, several cellular genes have been identified that func-
tion in addition to the innate and adaptive immune response to
limit virus infection and spread. These include members of the
APOBEC3 family of restriction factors, which encode DNA-
editing enzymes characterized by the presence of at least one
cytidine deaminase domain (LaRue et al., 2009). The number
of APOBEC3 genes varies between species, from one gene
in rodents to seven genes in humans (LaRue et al., 2009).
APOBEC3G and APOBEC3F confer intrinsic immunity to HIV-1
lacking the vif gene (Chiu and Greene, 2008; Cullen, 2006;
Malim, 2009). In vif-deficient-HIV-1 producer cells, APOBEC3G
and -3F are packaged into progeny virions, while in cells infected
with vif+ virus, Vif binds APOBEC3F and -3G and targets them
for degradation in the proteasome, thereby preventing their
packaging and overcoming the antiviral activity. Virion-pack-
aged APOBEC3 proteins inhibit infection in target cells by
deaminating deoxycytidine residues on the DNA minus strand
following reverse transcription, inducing mutations in newly
synthesized HIV-1 DNA; this leads to both degradation of
reversed transcribed DNA prior to integration and to mutation
of viral genes in the integrated provirus (Cullen, 2006; Malim,
2009). There is also evidence that APOBEC3 proteins can restrictvier Inc.
Figure 1. Infection of Tissues of mA3+/+ and
mA3–/– Mice after Milk-Borne Transmission of
MMTV
(A and B) RT-qPCR analysis of DNA isolated from spleen
and nonlactating mammary gland, respectively, using
MMTV- and GAPDH-specific primers; shown are the
MMTV values normalized to GAPDH. All error bars repre-
sent SD from the averages of the mice analyzed at each
time point. From 6 to 19 mice were analyzed for each
time point. *p% 0.02; **p% 0.001; #p% 0.01; comparison
is between mA3+/+ and mA3/ at each time point.
(C) Mammary tumor incidence in MMTV-infectedmA3/
and mA3+/+ mice after milk-borne infection. Shown are
Kaplan-Meier survival curves that were computed for
age at tumor onset. The p value for the test that these
two curves are significantly different (null hypothesis of
equality) was <0.0001. N = 26 mA3/ mice, 29 mA3+/+
mice.
Cell Host & Microbe
APOBEC3 and Virus Restriction in Mammary GlandHIV infection by non-CDA-dependent mechanisms (Malim,
2009).
APOBEC3 proteins also restrict infection by a number of
mouse retroviruses. Mice with targeted deletion of the Apobec3
gene are more susceptible to infection by MMTV and a number
of murine leukemia viruses (MLVs), all of which target cells of
hematopoietic origin in vivo (Langlois et al., 2009; Low et al.,
2009; Okeoma et al., 2007; Santiago et al., 2008; Takeda et al.,
2008). APOBEC3-mediated restriction of MMTV and Friend
MLV, but not AK virus infection, is independent of cytidine deam-
ination (Langlois et al., 2009; Okeoma et al., 2007; Takeda et al.,
2008). Because mothers can transfer viruses to their neonates
via milk, it is also possible that intrinsic immune factors like APO-
BEC3 proteins could limit milk-borne transmission. Here we
demonstrate that APOBEC3 proteins are expressed in mouse
and humanMECs andmammary tissue.We also show that APO-
BEC3 proteinmade inMECs is packaged into retrovirus particles
and affects viral infectivity. These data highlight the potential
importance of MEC-expressed APOBEC3 on the transmission
of milk-borne retroviruses.
RESULTS
APOBEC3 Knockout Mice Have Increased Mammary
Gland Infection
APOBEC3 RNA can be detected in cultured murine MECs and
primary mammary tissue (Okeoma et al., 2007; Pauklin et al.,
2009). To determine if APOBEC3 in mammary tissue restricts
in vivo virus infection, we foster-nursed APOBEC3 wild-type
(+/+) and knockout (/) mice on the same MMTV-infected
mothers and monitored infection of mammary gland from 3 to
10weeks after birth. MMTV infection of spleens served as a posi-
tive control, since this tissue was more highly infected in MMTV-
inoculated mA3/ mice than in mA3+/+ mice (Okeoma et al.,
2007). In addition, a cohort of MMTV-infected mA3+/+ and
mA3/ mice was monitored for mammary tumor induction.Cell Host & Microbe 8, 534–Mice lacking APOBEC3 had higher levels of
milk-borne MMTV infection of both splenic
and mammary tissue at all times examined
(Figures 1A and 1B). The difference in infectionin the wild-type and knockout mice changed with age, from
130-fold to 2-fold and from 17-fold to 3-fold from 3 to 10 weeks
in spleen and mammary tissue, respectively. The higher level
of infection in mA3/ mice also resulted in increased tumor
incidence and decreased time to tumor formation (Figure 1C);
at the conclusion of the analysis, 16 of 26 mA3/ developed
mammary tumors (average time to tumor = 382 days; median
time to tumor = 307 days) in contrast to 4 of 29 +/+ mice that
developed tumors (average time to tumor = 476 days; median
time to tumor = 483 days), while no uninfected mA3+/+ or
mA3/ mice developed mammary tumors (data not shown).
Thus, loss of APOBEC3-mediated restriction of MMTV infection
resulted in higher levels of mammary gland infection and thus
caused the virus to be more pathogenic in vivo.
Mammary Gland Infection Is Restricted by Lymphocyte
but Not Mammary Cell APOBEC3
The higher level of mammary gland infection leading to increased
mammary tumor formation inmA3/mice could result from lack
of APOBEC3-mediated restriction of MMTV spread within
lymphocytes, MECs, or both. To determine in which compart-
ment APOBEC3-mediated restriction occurred, we lethally irra-
diated mA3/ and mA3+/+ mice, reconstituted them with bone
marrow from mA3+/+ mice, and then infected them with MMTV.
Reconstitution was monitored by FACS analysis of peripheral
blood mononuclear cells for CD8+ and CD4+ T cells, CD11c+
DCs, and B220+ B cells; in all cases, no differences in reconsti-
tution were seen between the mA3+/+ and mA3/ mice (Fig-
ure 2A). In addition, RNA was isolated from the spleens, lymph
nodes, and mammary tissue of the reconstituted animals and
examined by reverse-transcribed PCR for APOBEC3. All
lymphoid tissue, but not the mammary gland of the mA3/
mice, expressed APOBEC3 RNA at levels similar to that seen
in the reconstituted mA3+/+ mice (Figure 2B).
Not surprisingly, given that the lymphoid tissues of themA3+/+
and mA3/ mice were equally reconstituted with the mA3+/+543, December 16, 2010 ª2010 Elsevier Inc. 535
Figure 2. Adoptive Transfer of Lymphocytes intomA3+/+ andmA3–/–
Mice
Five mice of each genotype were lethally irradiated, reconstituted with bone
marrow mA3+/+ mice, infected with MMTV, and then sacrificed 9 weeks after
irradiation.
(A) FACS analysis of reconstitutedmice. PBLswere isolated from the individual
mice at sacrifice and stained with the indicated antibodies. Error bars repre-
sent SD from the average for the five mice of each genotype.
(B) RNA was isolated from the spleen, lymph nodes (LN), and mammary gland
(MG) and subjected to reverse-transcribed PCR with primers specific for
APOBEC3.
(C) DNA was isolated from the indicated tissue and subjected to RT-qPCR
specific for exogenous MMTV(RIII) sequences. Values were normalized to
GAPDH. This experiment was repeated two additional times with similar
results.
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node was not significantly different between the two sets of
mice (Figure 2C). However, although no APOBEC3 RNA was
detected in the mammary tissue of the reconstituted mA3/
mice, infection levels were equal to that seen in the reconstituted
mA3+/+ mice, which did express APOBEC3 (Figure 2C). These
data strongly suggested that MMTV infection of MECs was
determined by lymphocyte virus load and that restriction by
APOBEC3 occurred in lymphocytes but not epithelial cells.
APOBEC3 Expressed in Mammary Tissue Is Packaged
into Milk-Borne Virions and Restricts Infection
MECs are the only source of cell-free MMTV in vivo, which is
believed to be the major form of milk-transmitted virus (Nandi
and McGrath, 1973). If APOBEC3 made in MECs was packaged536 Cell Host & Microbe 8, 534–543, December 16, 2010 ª2010 Elseinto MMTV virions, it would limit virus transmission of milk-borne
virus. We next tested the infectivity of virus produced in MMTV-
infected mA3/ and mA3+/+ mammary glands; in both strains,
MMTV was transmitted through milk for five generations or
more. Virions were purified from the milk of the mA3+/+ and
mA3/ mice, and RNA isolated from these virions was quanti-
fied by reverse transcribed RT-qPCR. There was about 10-fold
more virus in the milk produced by mA3/ mice compared to
mA3+/+mice (Figure 3A), which reflects the higher infection levels
in the former (Figure 1B).
To show that APOBEC3 was packaged into virions made in
mammary tissue, virus was isolated from the mammary tumors
of mA3+/+ and mA3/ mice; mammary tumor tissue has long
been used as a source of MMTV (Golovkina et al., 1994). We
also analyzed splenic extracts from mA3+/+ and mA3/ mice,
as well as 293T cells transduced with plasmids encoding
HA-tagged BL/6 and BALB/c APOBEC3 proteins (Takeda
et al., 2008). Because of allelic differences that cause differential
splicing of the RNA in BL/6 versus BALB/c mice, the predomi-
nant APOBEC3 RNA produced in C57BL/6 mice lacks exon 5
and is 3.6 kDa smaller than the full-length BALB/c 51 kDa
protein (Okeoma et al., 2009; Takeda et al., 2008). No APOBEC3
protein was found in either the spleen or virus frommA3/mice.
In contrast, delta exon 5 APOBEC3 protein was detected in both
the spleen and virions isolated from mA3+/+ mammary glands
(Figure 3B).
To examine the infectivity of the milk-borne mA3+/+ and
mA3/ virus, serial dilutions were used to infect 293T-mTfR1
cells (293T cells stably expressing the MMTV entry receptor,
transferrin receptor 1), and DNA was isolated from the infected
cells and subjected to RT-qPCR to determine the level of infec-
tion. Because of the difference in the amount of virus produced in
the two strains of mice, the infection levels are presented after
normalization to virion RNA levels. Even after normalization, we
found that the virus from mA3/ mice infected cells at higher
levels than that isolated from mA3+/+ mice (Figure 3C). Taken
together with the protein analysis in Figure 3B, these data indi-
cate that murine APOBEC3 is packaged into milk-borne virions
and limits infectivity.
APOBEC3G Is Expressed in Human Mammary
Epithelial Cells
We next examined human MECs, to determine whether any of
the human APOBEC3 genes were also expressed these cells.
We performed reverse-transcribed RT-qPCR with APOBEC3G-,
APOBEC3F-, APOBEC3A-, APOBEC3B-, and APOBEC3H-
specific primers with RNA isolated from four different cultured
MEC lines (MCF7, MCF10, HS578T, T47D) and primary human
mammary tissue. APOBEC3G RNA was detected in HS578T
and MCF10 cells, as well as all the primary tissue RNAs (Fig-
ure 4A) at approximately 10-fold lower levels than the H9 T cell
line (see Figure S1 available online). In contrast, APOBEC3G
RNA was almost undetectable in MCF7 and T47D cells. Very
low levels of APOBEC3A, -3F, and -3H RNA were found in all
four cell lines, only MCF7 cells produced APOBEC3A RNA and
T47D, and HS578T and MCF7 but not MCF10 cells contained
3B RNA (Figure S1 and data not shown). All of the tested
APOBEC3 RNAs were detected in primary mammary tissue,
with the exception of APOBEC3H (Figure S2).vier Inc.
Figure 3. Virus Isolated from mA3–/– Milk Is
More Infectious Than that Isolated from
mA3+/+ Milk
(A) Virions were isolated from the milk of MMTV-
infected mA3/ and mA3+/+ mice and RNA iso-
lated from equal amounts of milk was subjected
to reverse-transcribed RT-qPCR. Error bars
represent the SD of 11 mA3/ and 9 mA3+/+
milk samples.
(B) Western blot analysis of APOBEC3 in tissues
and virions. Lanes 1 and 2, 293T cells transfected
with expression vectors containing the BL/6 delta
exon 5 (5) or BALB/c + exon 5 (+5) cDNAs; lanes
3 and 4, splenic extracts from mA3+/+ mice;
lanes 5 and 6, splenic extracts from mA3/
mice; lanes 7 and 8, virions isolated from the
mammary tissue of mA3+/+ (A3+, lane 7) or
mA3/ (A3, lane 8) mice. The top panel was
probed with rabbit anti-mouse APOBEC3 anti-
sera, then stripped and reprobed with goat anti-
MMTV antisera (middle panel); the bottom panel
is a duplicate blot of the same extracts probed
with anti-b-actin. A cross-reacting protein that
is present in the tissue extracts of both +/+
and / mice is indicated by a dotted arrow;
this protein was detected in some but not all
virus preparations irrespective of the presence
of APOBEC3 (data not shown).
(C) Various dilutions of virus isolated frommA3/ andmA3+/+ milk were used to infect 293-mTFR1 cells in triplicate, and DNAwas isolated from the infected cells
and subjected to RT-qPCR for MMTV and GAPDH. The numbers presented were normalized to the amount of virion RNA asmeasured in (A). Error bars represent
SD from three replicate wells. p% 0.001 for both dilutions.
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of several human APOBEC3 genes (Pauklin et al., 2009). We also
tested whether progesterone or the synthetic glucocorticoid
dexamethasone induced expression of APOBEC3G in HS578T
and T47D cells. HS578T cells are estrogen receptor (ER) and
progesterone receptor (PR) negative, whereas T47D cells are
both ER and PR positive; both cell lines have the glucocorticoid
receptor (GR) (Buser et al., 2007; Keydar et al., 1979; Small
et al., 1999). No hormones significantly changed the level of
APOBEC3G RNA in HS578T cells (Figure 4B). In contrast, gluco-
corticoids, estrogen, and progesterone all induced expression of
APOBEC3G in T47D cells. APOBEC3A was induced by dexa-
methasone in both HS578T and T47D cells, there was no effect
by any hormone on APOBEC3B or -3F in either cell line, and
APOBEC3H levels were low even in the presence of hormones
(Figure S3).
We also examined APOBEC3G protein expression in the
human cell lines and tissue. Using immunoprecipitation followed
by western blot analysis, APOBEC3G protein was detected in
untreated HS578T but not the other MEC lines (Figure 5A and
data not shown), in agreement with the higher RNA levels in
HS578T cells (Figure 4A). APOBEC3G protein was also detected
in progesterone-induced T47D cells (Figure 5A). In both HS578T
and T47D cells, APOBEC3G protein expression was at least
10-fold lower than that detected in H9 cells, consistent with
the relative RNA levels in the different cell lines (Figure S1). We
also performed indirect immunohistochemistry on HS578T and
T47D cells. Abundant cytoplasmic staining, with occasional
punctuate structures, was detected in HS578T but not T47D
cells (Figure 5B). This pattern of staining is similar to that previ-Cell Host &ously reported for APOBEC3G (Gallois-Montbrun et al., 2007,
2008; Mangeat et al., 2003; Wichroski et al., 2006). Although
the rabbit antisera we used also recognizes APOBEC3A (Thielen
et al., 2010), both HS578T and T47D cells had very low levels of
APOBEC3A RNA (Figures S1 and S3), and we did not see a band
of the appropriate molecular weight in the immunoprecipitation/
western blot analyses of extracts from these cells (data not
shown).
Additionally, three different primary human mammary gland
samples were stained with anti-APOBEC3G antisera (Newman
et al., 2005); Figure 6 shows a representative section from one
of these samples. APOBEC3G protein was detected in the
luminal epithelial cells of the intralobular mammary duct. This
staining was not seen in sections incubated with normal rabbit
serum and or with anti-ABOBEC3G antisera in the presence of
recombinant APOBEC3G (r3G) protein. In addition, occasional
stromal cells showed reactivity with anti-APOBEC3G antisera
which was also blocked by r3G protein. The immunostaining
both in cultured mammary cells and primary tissue was predom-
inantly cytoplasmic, indicating that the antisera were recognizing
APOBEC3G. However, since we did detect APOBEC3A RNA in
primary human mammary tissue (Figure S2), it is also possible
that the epithelial or stromal cell staining in mammary tissue
was due at least in part to APOBEC3A protein, which has
predominantly been found in the nucleus (Chen et al., 2006).
Vif Increases Infectivity of HIV-1 Virions Produced
in MECs
We next performed a proof-of-principle experiment to test
whether MEC-expressed APOBEC3 proteins could restrict virusMicrobe 8, 534–543, December 16, 2010 ª2010 Elsevier Inc. 537
Figure 4. APOBEC3G Is Made in Human Mammary Epithelial Cells
(A) RNA was isolated from MCF7, MCF10, HS578T, and T47D mammary cell
lines, and from seven different primary mammary gland samples from normal,
nonlactating females (P1–P7) and subjected to reverse-transcribed RT-qPCR,
using primers to APOBEC3G. All values were normalized to GAPDH. The
values for the HS578T cell line were set at 1.0, and the results from the other
cells and tissues are normalized to this value.
(B) Reverse-transcribed RT-qPCR analysis of RNA isolated from the indicated
cell lines after 48 hr treatment with estrogen (E), progesterone (P), or dexa-
methasone (D);  indicates untreated cells. Error bars represent the SD of
three replicate wells of each cell line/treatment. *NS; **p % 0.04; #p % 0.01;
+p% 0.02. See also Figures S1–S3.
Figure 5. APOBEC3G Protein Is Made in Human MECs
(A)Western blots of lysatesmade from the differentMECs following 48 hr treat-
ment with (+) or without () progesterone. Also included are lysates prepared
from 293T (APOBEC3G) and H9 (APOBEC3+) cells. Arrow points to
APOBEC3G.
(B) Indirect immunofluorescence of HS578T and T47D cells, using anti-
APOBEC3G antisera. Cells were counterstained with DAPI. Left panel, IF
plus DAPI; right panel, IF alone.
Figure 6. APOBEC3G Protein Is Made in Primary Human Mammary
Tissue
Indirect IF of primary mammary tissue was performed, using rabbit anti-
APOBEC3G antisera in the absence (a-A3G) or presence (a-A3G +r3G) of
recombinant APOBEC3G protein. An enlargement of the outlined area of the
lumen is shown to the right of the top panel. Yellow arrow, luminal epithelial
cells; white arrow, stromal cell.
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vectors PNL-luc+vif and PNL-luc-vif and a plasmid bearing the
vesicular stomatitis virus (VSV) G protein. The transfected cells
were grown in the presence and absence of progesterone to
induce APOBEC3G expression. If APOBEC3G was packaged
into HIV-1 virions in MECs, then vif+ virions should be more
infectious than vif virus when produced by these cells. Addi-
tionally, HIV produced by progesterone-treated T47D but not
HS578T cells should be less infectious, since APOBEC3G levels
were increased in response to hormone in the former and not the
latter cell line. Virus was isolated from the supernatants of these
cells, analyzed by western blot analysis and ELISA for Gag
protein, and then used to infect NP2 cells.
First, we found that PNL-Luc+vif virus was more infectious
than PNL-Luc–vif virus, when produced in HS578T cells (Fig-
ure 7A), indicating that endogenously produced APOBEC3G
may be packaged into virions and that this was counteracted
by Vif. No difference in infectivity was seen when virus was
produced from HS578T cells grown in the presence or absence
of progesterone (Figure 7A), consistent with the observation that
progesterone does not induce APOBEC3G expression in this cell
line (Figure 5A). However, virus produced by progesterone-538 Cell Host & Microbe 8, 534–543, December 16, 2010 ª2010 Elsetreated T47D cells was less infectious than that produced in
untreated cells (Figure 7A). The presence of vif in the vector did
not alter the infectivity of virus produced in T47D cells that
received no progesterone (Figure 7A), most likely because therevier Inc.
Figure 7. APOBEC3G Made in MECs Is Packaged into HIV
(A) HS578T (left) and T47D (right) cells were transducedwith PNL-Luc that con-
tained (+vif) or lacked (vif) the vif gene and a vector bearing the VSVGprotein.
Twenty-four hours posttransduction, progesterone was added to the media as
indicated (+) or left untreated (), and 24 hr later virus was harvested from the
cell supernatants and used to infect NP2 cells, in the absence or presence of
AZT, as indicated. In addition, p24 levels were measured by ELISA. Twenty-
four hours after infection, luciferase assays were performed on lysates
prepared from the NP2 cells. RLUs were normalized to the p24 levels in the
virus preparations. Error bars represent SD from three replicate infections.
*NS; **p % 0.05; #p % 0.001. This experiment was performed three times
with similar results.
(B) The virion preparations were analyzed by western blots, using anti-p24
antisera. Virions prepared in PNL-Luc+vif-transduced 293T cells were
included as positive controls.
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ures 5A and 5B). However, PNL-Luc+vif virus was more infec-
tious than PNL-Luc-vif virus when produced in T47D cells
treated with progesterone (Figure 7A), indicating that the
increased APOBECG produced in hormone-treated cells was
counteracted by Vif. We also performed western blots on the
virions produced by MECs, but although we could detect Gag
protein (Figure 7B) and APOBEC3G protein was detectable in
cell extracts (Figure 5A), the low levels of virus produced
precluded detection of APOBEC3G in virions. Although both
T47D and HS578T cells also expressed APOBEC3B RNA, which
could play a role in restricting HIV produced in these cells,
expression of this factor was not induced by progesterone.
Moreover, APOBEC3B has weaker anti-HIV activity than
APOBEC3G (Rose et al., 2005), and it is not highly inhibited
by Vif (Doehle et al., 2005; Marin et al., 2008). Thus, our data indi-
cate that APOBEC3G expressed in MECs may be packaged in
HIV-1 virions and has antiviral activity that can be counteracted
by Vif.Cell Host &DISCUSSION
A large number of intrinsic immune factors that restrict virus
infection in a variety of cell types have been identified in the
past few years, in large part through study of viral proteins
such as the HIV-1 Vif protein that counteract their action (Goff,
2004). Although APOBEC3G was first identified as an antiviral
factor in HIV-1 infection, APOBEC3 proteins have been shown
to function as anti-viral factors against not only retroviruses
but also against diverse viruses such as HBV, foamy viruses,
HPV, and parvoviruses and there is much interest in developing
antiviral therapies that increase the ability of APOBEC3 to
inhibit viral infection. However, while much has been learned
about how this family of antiviral factors functions using cell
culture models, less is known about how APOBEC3 proteins
function in vivo. Recent studies in whichmice with targeted dele-
tion of the Apobec3 gene were infected with different mouse
retroviruses have begun to increase our understanding of how
APOBEC3 proteins decrease the pathogenic effects of in vivo
infection.
Here we show that MECs express APOBEC3 that is pack-
aged into virions and restricts infectivity. In mice, APOBEC3
is expressed in lymph nodes (T, B, and DCs) at the highest
levels, followed by adipose and epithelial tissues such as
the mammary gland (Mikl et al., 2005; Okeoma et al., 2007;
Su et al., 2004). Our studies demonstrate that APOBEC3 limits
MMTV infection of the lymphoid compartment in vivo and that
this restriction results in lower levels of virus infection in
mammary tissue, accompanied by a decreased incidence in
mammary tumorigenesis. These data are consistent with our
previous studies showing that MEC infection in mammary
tissue depends on the level of lymphoid cell infection (Golov-
kina et al., 1998). Although APOBEC3 is made in MECs, its
absence in this cell type in knockout mice reconstituted with
wild-type bone marrow did not alter in vivo mammary gland
infection.
Although virus infection levels in MECs themselves were not
affected by the loss of APOBEC3, APOBEC3 protein produced
in mammary tissue was packaged into virions. While there are
numerous studies using transfected and primary cells as well
as knockout mice to study the effect of APOBEC3 proteins
on virus infection and spread, the current study provides direct
demonstration that endogenous APOBEC3 protein is pack-
aged into virions in vivo. The presence of APOBEC3 in
MMTV virions resulted in a significant decrease in the relative
infectivity of MMTV shed in the milk of wild-type versus
knockout mice. Our data thus suggest that APOBEC3 expres-
sion in MECs is retained in mice as a way of limiting milk-borne
transmission of MMTV, and perhaps other mouse viruses;
several studies have indicated that the natural transmission
route of MLV, which is also restricted by APOBEC3, is through
milk (Duggan et al., 2006; Jenson et al., 1976). Milk-borne virus
transmission in mice may also be affected by genetic varia-
tions in Apobec3. C57BL/6-derived and BALB/c mice have
a number of polymorphic differences in both the coding and
noncoding regions of Apobec3, and the BL/6 allele has been
shown to be expressed at higher levels in vivo, as well as
more effective at restricting infection by F-MLV, AK virus,
and MMTV (Langlois et al., 2009; Okeoma et al., 2009; TakedaMicrobe 8, 534–543, December 16, 2010 ª2010 Elsevier Inc. 539
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isolated from the mammary tumors or milk of C57BL/6 mice
were less infectious than those produced in BALB/c mice
(Okeoma et al., 2009).
We also show here that APOBEC proteins expressed in
human MECs have the potential to restrict virus infectivity.
Human APOBEC3F, -3G, and -3C are expressed at high levels
in spleen, lymphocytes, DCs, and monocytes, while APOBEC3B
is highly expressed in cancer cells, B lymphoblasts, and
endothelial cells and APOBEC3A in immature monocytes
(Aguiar and Peterlin, 2008; Koning et al., 2009; Refsland et al.,
2010; Su et al., 2004). We detected APOBEC3A, -3B, -3F, and
-3G RNA in primary mammary tissue (Figure S3), but only
APOBEC3B and APOBEC3G were highly expressed in cultured
MECs (Figure 4A and Figure S1). This difference may be due
to the presence of diverse cell types in the primary tissue
(MECs, stromal cells, vascular cells, lymphoid cells, etc.);
indeed, we detected APOBEC3G protein in both ductal epithe-
lial and stromal cells in primary tissue (Figure 6). This differential
expression may play a role in how APOBEC3 proteins restrict
infection by diverse viruses in different tissues. The most potent
inhibitors of HIV infection, APOBEC3G and -3F, are highly
expressed in HIV-target lymphoid cells, while APOBEC3A,
-3B, and -3H, also expressed in keratinocytes and skin, could
play a role in restricting human papilloma virus infection (Varta-
nian et al., 2008).
In contrast to MMTV, it is unclear whether milk-borne trans-
mission of lentiviruses and delta viruses is cell-free or cell asso-
ciated and whether lymphoid or mammary cells or both are the
virus reservoir (Becquart et al., 2002; Bobat et al., 1997; Hender-
son et al., 2004; Hino et al., 1994; Koulinska et al., 2006; Law-
rence and Lawrence, 2004; Leroy et al., 1998; Lewis et al.,
1998; Li et al., 2004; Miotti et al., 1999; Pandrea et al., 2008;
Rousseau et al., 2003, 2004; Rychert et al., 2006; Ziegler et al.,
1985). Cultured human MECs can be productively infected
with HTLVI (LeVasseur et al., 1998), and several studies have
shown that human MECs express low levels of CXCR4 and
can be infected by CXCR4-tropic HIV-1; at least in tissue culture
cells, these cells produce infectious virus (El Messaoudi et al.,
2000; Moriuchi and Moriuchi, 2004; Su et al., 2004; Toniolo
et al., 1995). A more recent study has suggested that while
primary MECs express CD4, CCR5, and CXCR4, they are not
productively infected with HIV-1 but instead sequester the virus
in endosomal compartments which could then facilitate infection
of CD4+ T cells in the mammary gland (Dorosko and Connor,
2010).
Although it is unclear whether APOBEC3G in mammary tissue
plays a role in restricting milk-borne HIV infection, it is interesting
that this factor, the major anti-HIV family member, as well as
APOBEC3A and -3B, were all highly expressed in primary
mammary tissue. It may be that these factors are important for
restricting milk-borne transmission of other viruses. For
example, APOBEC3A has also been implicated in the restriction
of papillomavirus infection, which some studies have shown to
be present in human MECs and mammary tumors (de Villiers
et al., 2005). That APOBEC3RNA and protein are found in human
mammary tissue suggests that this intrinsic antiviral factor may
have been retained as a means of limiting milk-borne virus trans-
mission in humans as well as in mice.540 Cell Host & Microbe 8, 534–543, December 16, 2010 ª2010 ElseEXPERIMENTAL PROCEDURES
Ethics Statement
All human tissues were received as unidentified archived biopsied tissue from
the Tumor Tissue and Biospecimen bank from the University of Pennsylvania.
The use of these specimens received exemption from the University of
Pennsylvania Institutional Research Board. All mice were housed according
to the policies of the Institutional Animal Care and Use Committee of the
University of Pennsylvania, and all experiments performed with mice were
approved by this committee.
Cell Lines and Human Tissue
293T, HS578T, MCF 7, MCF 10A (nontumorigenic MEC line), and T47D cell
lines were purchased from American Type Culture Collection. H9 and NP2
cells were obtained from Robert Doms and Jim Hoxie, respectively. 293T-
mTfR1 cells have been previously described (Zhang et al., 2003); MMTV infec-
tion of these cells was analyzed by RT-qPCR for viral DNA sequences
(Okeoma et al., 2009). All cells were maintained according to the suppliers’
instructions. Primary human mammary tissues were obtained from the Univer-
sity of Pennsylvania’s tissue bank in accordance with IRB guidelines and after
pathologic review.
Foster Nursing and Tumorigenesis Studies
The mA3-knockout (mA3/) and matched control (mA3+/+) mice were previ-
ously described (Okeoma et al., 2007). Age-matched pups from mA3/ and
mA3+/+ MMTV females were foster nursed on C57BL/6 MMTV(RIII)+ females.
The foster-nursed pupswere sacrificed at the indicated times. Different tissues
were harvested for DNA isolation and analysis of infection by real-time quan-
titative polymerase chain reaction (RT-qPCR) for integrated MMTV proviruses;
all values were normalized to GAPDH, as previously described (Courreges
et al., 2007). Foster-nursed mA3+/+ and mA3/ female mice were kept in
constant mating and palpated weekly for mammary tumors; all mice were
sacrificed at the time of tumor detection.
Adoptive Transfers
FiveMMTV– age-matched (6 weeks old)mA3+/+ andmA3/ femalemice each
were lethally irradiated using a Cs-137 irradiator (g cell 40 Extractor; MDS
Nordion). Four hours after irradiation, the mice were reconstituted with bone
marrow stem cells from MMTV– mA3+/+ mice. One week after reconstitution,
the mice were inoculated with MMTV(RIII) isolated from milk and then sacri-
ficed 9 weeks after irradiation. Prior to sacrifice, peripheral blood lymphocytes
from each mouse were subjected to FACs analysis with conjugated anti-
mouse CD8, CD4, CD11c, and B220 (BD-PharMingen) to test for uniform
reconstitution. At sacrifice, RNA was isolated from lymph nodes, spleens,
and mammary glands and subjected to mouse reverse transcribed PCR with
primers specific to mouse APOBEC3, and DNA was isolated and analyzed
byRT-qPCRwith primers specific toMMTV andGAPDH (Okeoma et al., 2007).
Mouse APOBEC3 RNA and Protein Analysis
RNA was isolated from milk-borne virions and subjected to reverse-tran-
scribed RT-qPCR as previously described (Okeoma et al., 2009). Virions,
as well extracts from tissues and 293T cells transiently transfected with
mouse APOBEC3 expression vectors (+ and – exon 5; Takeda et al., 2008),
were subjected to western blot analysis with the indicated antibodies.
Rabbit anti-mouse APOBEC3 antisera were generated by immunizing
rabbits with a hapten-coupled peptide unique to the mouse protein
(CSHRKCYSPIRNLISQE) (Lampire Biological Laboratories) followed by affinity
purification of the antisera. The goat anti-MMTV antisera were originally ob-
tained from the National Cancer Institute Biochemical Carcinogenesis Branch
Repository, Bethesda, MD. Detection was accomplished using the species-
appropriate horseradish peroxidase-conjugated secondary antibody followed
by ECL (Amersham Biosciences, Inc.).
Human APOBEC3 RNA and Protein Analysis
Cells were cultured for 48 hr in the presence or absence of 1 mM17-b-estradiol,
dexamethasone, or progesterone (all purchased from Sigma-Aldrich). RNA
was isolated fromMCF7, MCF10, HS578T, and T47D cells and primary tissues
using RNAEasy kits (QIAGEN, Inc.) and subjected to reverse-transcribedvier Inc.
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APOBEC3 and Virus Restriction in Mammary GlandRT-qPCR, with primers to APOBEC3A, -B, -F, -G, and -H (Table S1). To ensure
that the reverse-transcribed RT-qPCR products were specific to the corre-
sponding Apobec3 gene, the cDNA amplicons were sequenced and the iden-
tity of the transcript was confirmed (data not shown). APOBEC3G protein
expression was analyzed by immunoprecipitation of extracts prepared from
HS578T and T47D cells with anti-APOBEC3G monoclonal antibody (murine
anti-human APOBEC3G (CEM15) #10069), followed by western blot analysis
with a rabbit anti-APOBEC3G antisera (#10201; Thielen et al., 2007); both
were obtained from the AIDS Research and Reference Reagent Program.
Packaging of hA3G into HIV-1 Virions Produced in Human MECs
The PNL LUC-vif and PNL LUC-Dvif plasmids were kind gifts from Matija
Peterlin (Connor et al., 1995). The PNL-Luc vectors (+/ vif) viruses pseudo-
typed with VSV-G were generated by plasmid cotransfection of 293T,
HS578T, and T47D cells using Lipofectamine 2000 (Invitrogen, Inc.). Twenty-
four hours after transfection, progesterone was added to the media and
48 hr later virus was harvested from the supernatants. Virions were purified
from culture supernatant by centrifugation at 500 3 g, followed by filtration
through a 0.45 m sterile membrane filter (Millex-HV; Millipore), and pelleting
through a 20% sucrose cushion by centrifugation at 105,0003 g for 1 hr. Puri-
fied virions were used to infect NP2 cells in the absence or presence of AZT.
Forty-eight hours after infection, cells were harvested and extracts subjected
to luciferase assays. Luciferase relative light units (RLUs) were normalized to
the p24 levels in the virus preparations. The p24 ELISAs were performed by
the University of Pennsylvania Center for AIDS Research Immunology Core.
The virions were also analyzed by western blot analysis with anti-p24 antisera,
a kind gift from Robert Doms.
Immunofluorescence
HS578T and T47D cells were cultured on poly-L-lysine (Sigma)-coated cover-
slips. Twenty-four hours later, cells were fixed with paraformaldehyde.
Mammary specimens (formalin-fixed and paraffin-embedded) were cut into
4 micron thick sections using a microtome and mounted on charged slides.
Sections were deparafinized and rehydrated, and then the antigen binding
sites were unmasked (antigen unmasking solution; Vector Labs) at 98C for
20 min. All samples were permeabilized with 0.1% Triton X-100, and nonspe-
cific binding sites were blocked with normal goat serum in the presence of
avidin (Vector Labs) for 1 hr at room temperature. Samples were washed
and reacted with polyclonal rabbit anti-APOBEC3G antibody in the absence
and presence of recombinant APOBEC3G (NIH AIDS Research and Reference
Reagent Program) or normal rabbit serum (Santa Cruz Biotechnology) in the
presence of biotin (Vector Labs) for 1 hr at room temperature, washed, and
then incubated with biotin-labeled goat anti-rabbit IgG for 30 min at 37C.
The APOBEC3G-positive signal was detected with FITC-streptavidin. Images
were taken with a LEICA DM1000 fluorescent microscope using a Nuance
multispectral imaging camera and Nuance software (Cambridge Research
Instrumentation Inc, Woburn, MA).
Statistical Analysis
Statistical analysis of significant differences between experimental groups
was tested using paired two-tailed Student’s t test. Error bars represent stan-
dard deviations. For the Kaplan-Meier survival curve (Figure 1D), statistical
analyses were done using SAS/STAT software, Version 9 of the SAS System
for Windows.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and one table and can be found
with this article online at doi:10.1016/j.chom.2010.11.003.
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